Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jul 19, 2022

50715_rns_2022-07-19_c422b61a-e51c-481a-8325-b82033fd0a08.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

19 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Description
of relevant
securities
Nature of dealings Purchase
/ Sale
Total
number of
shares
involved
Total
amount paid
/ received
Highest (H)
prices paid
/ received
Lowest (L)
prices paid
/ received
CICC Pucheng
Investment Co.,
Ltd.
18 July 2022 Other types
of securities
(e.g. equity
swaps)
Closing / flattening / unwinding of
proprietary positions arising from
unsolicited client-driven dealings.
I confirm this was done no later
than the close of the morning
trading session on the trading day
following the orginating
client-driven dealing
Purchase 2,000 $48,200.0000 $24.1000 $24.1000

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Other types
of securities
(e.g. equity
swaps)
Closing / flattening / unwinding of
proprietary positions arising from
unsolicited client-driven dealings.
I confirm this was done no later
than the close of the morning
trading session on the trading day
following the orginating
client-driven dealing
Sale 2,000 $48,109.4600 $24.0547 $24.0547

End

Note:

CICC Pucheng Investment Co., Ltd. is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

CICC Pucheng Investment Co., Ltd. is ultimately owned by China International Capital Corporation Limited.